Wednesday, October 25th, 2017 - Copenhagen
The proactive role of pharmacovigilance is a key part of the life cycle of the drug to ensure safety of the patients. The 4th Nordic Pharmacovigilance Day will focus on new PV challenges related to systems (e.g. ICSR handling and signal detection in the new Eudravigilance database), new and updated legislation inside and outside Europe, and new areas like social media. With increasing regulatory expectations and innovative initiatives in and outside Europe, it becomes imperative to collate the thoughts of all stakeholders of pharmacovigilance. The conference looks forward to accomplishing this task with a great deal of passion and commitment.
The Scientific Board:
Anne Gramkow, Head of Drug Safety, QPPV at Pharmacosmos
Martin Holm-Petersen, CEO at Insife
Betina Østergaard Eriksen, Vice President, Safety Surveillance at Novo Nordisk
will lead a panel of experts to share best practices, knowledge and experience in this field.
This one-day conference is designed to benefit functional/technical professionals working in the pharmaceutical and health care system dealing with the Pharmacovigilance system, such as:
• Pharmacovigilance dept.
• Regulatory Affairs dept.
• Clinical operations dept.
• Statistic dept.
• Medical Affairs dept.
• Audit/Inspection dept.
In Pharmaceutical and Biotechnology Companies, Clinical Research Organizations (CROs), Academic Centres, Hospital Centres, and Clinical Technology companies especially concerned with the implementation and/or maintenance of Pharmacovigilance/Vigilance Systems, with its critical processes and quality system.